 - Use of nasal or inhaled corticosteroids, intraophthalmic corticosteroids, nasal, inhaled, or intraophthalmic cromolyn sodium or nedocromil, leukotriene receptor antagonists zafirlukast, pranlukast, montelukast, and 5-lipoxygenase inhibitors zileuton within 28 days prior to first screening and throughout the study. 